Abstract:Background: Ultrasound features help to differentiate benign from malignant masses, and some of them are included in the ultrasound (US) scores. The main aim of this work is to describe the ultrasound features of certain adnexal masses of difficult classification and to analyse them according to the most frequently used US scores. Methods: Retrospective studies of adnexal lesions are difficult to classify by US scores in women undergoing surgery. Ultrasound characteristics were analysed, and masses were classified according to the Subjective Assessment of the ultrasonographer (SA) and other US scores (IOTA Simple Rules Risk Assessment-SRRA, ADNEX model with and without CA125 and O-RADS). Results: A total of 133 adnexal masses were studied (benign: 66.2%, n:88; malignant: 33.8%, n:45) in a sample of women with mean age 56.5 ± 7.8 years. Malignant lesions were identified by SA in all cases. Borderline ovarian tumors (n:13) were not always detected by some US scores (SRRA: 76.9%, ADNEX model without and with CA125: 76.9% and 84.6%) nor were serous carcinoma (n:19) (SRRA: 89.5%), clear cell carcinoma (n:9) (SRRA: 66.7%) or endometrioid carcinoma (n:4) (ADNEX model without CA125: 75.0%). While most teratomas and serous cystadenomas have been correctly differentiated, other benign lesions were misclassified because of the presence of solid areas or papillae. Fibromas (n:13) were better identified by SA (23.1% malignancy), but worse with the other US scores (SRRA: 69.2%, ADNEX model without and with CA125: 84.6% and 69.2%, O-RADS: 53.8%). Cystoadenofibromas (n:10) were difficult to distinguish from malignant masses via all scores except SRRA (SA: 70.0%, SRRA: 20.0%, ADNEX model without and with CA125: 60.0% and 50.0%, O-RADS: 90.0%). Mucinous cystadenomas (n:12) were misdiagnosed as malignant in more than 15% of the cases in all US scores (SA: 33.3%, SRRA: 16.7%, ADNEX model without and with CA125: 16.7% and 16.7%, O-RADS:41.7%). Brenner tumors are also difficult to classify using all scores. Conclusion: Some malignant masses (borderline ovarian tumors, serous carcinoma, clear cell carcinoma, endometrioid carcinomas) are not always detected by US scores. Fibromas, cystoadenofibromas, some mucinous cystadenomas and Brenner tumors may present solid components/papillae that may induce confusion with malignant lesions. Most teratomas and serous cystadenomas are usually correctly classified.

OP06.03: Preoperative sonographic evaluation of adnexal masses using the new Ovarian‐Adnexal Reporting and Data System

EP23.17: Ovarian‐Adnexal Reporting and Data System magnetic resonance imaging score in evaluating sonographically indeterminate adnexal masses

EP23.03: Adnexal masses in pregnancy

OC04.03: Preoperative assessment of non‐resectability in ovarian cancer according to ESGO criteria: a prospective multicentre study using imaging (ISAAC study)

OP06.01: Head‐to‐head comparisons of RMI and ADNEX model to diagnose ovarian malignancy: systematic review and meta‐analysis

EP06.33: Ultrasound features, prognostic of surgical intervention in fetal ovarian cysts

OP03.06: Ultrasonographic features and analysis of primary tubal carcinoma

OP06.04: Discrimination of benign and malignant adnexal masses in daily clinical routine: external validation of ADNEX and RMI in Denmark – preliminary results

EP23.19: Diagnostic accuracy of ultrasound scoring systems in differentiating benign versus malignant adnexal masses

EP23.37: Ultrasonography experience may not be a reliable indicator for improved accuracy in assessing malignancy in adnexal tumours using the ADNEX model

OP17.06: Diagnosing adenomyosis using transvaginal contrast‐enhanced ultrasound: a pilot study

Adnexal Masses in Pregnancy: A Single-Centre Prospective Observational Cohort Study

Imaging techniques for the pre-surgical diagnosis of adnexal tumours

OP03.03: Role of artificial intelligence applied to ultrasound in gynecology oncology: a systematic review

EP22.04: The accuracy of ultrasound in diagnosing adhesions around omental metastatic lesions of ovarian cancer

Application of Ultrasound Scores (Subjective Assessment, Simple Rules Risk Assessment, ADNEX Model, O-RADS) to Adnexal Masses of Difficult Classification

EP23.65: Serum Ca‐125 levels in postmenopausal women with adnexal masses and risk stratification based on Ovarian‐Adnexal Reporting and Data System

OC01.04: *AI‐driven ultrasound detection of ovarian cancer that generalises: an international multicentre validation study

EP23.14: Diagnostic accuracy of adnexal malignancy assessment models ADNEX and simple rules when applied by individuals with no prior clinical experience

OP03.05: Detection of Vulvar International Tumor Analysis criteria among sonographers in lymph node evaluation: interrater reliability study

EP23.23: Diagnosis of adnexal lesions using ultrasound‐based artificial intelligence